-
Je něco špatně v tomto záznamu ?
Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate
M Petrik, A Laznickova, M Laznicek, MR Zalutsky
Jazyk angličtina Země Řecko
Typ dokumentu srovnávací studie
NLK
Free Medical Journals
od 2004 do Před 2 roky
Open Access Digital Library
od 2004-01-01
- MeSH
- cyklické peptidy chemie metabolismus MeSH
- financování organizované MeSH
- glukosa analogy a deriváty metabolismus MeSH
- heterocyklické sloučeniny monocyklické chemie metabolismus MeSH
- izotopové značení MeSH
- krevní proteiny metabolismus MeSH
- krysa rodu rattus MeSH
- lutecium chemie MeSH
- potkani Wistar MeSH
- radiofarmaka chemická syntéza metabolismus MeSH
- radioizotopy india chemie MeSH
- radioizotopy jodu chemie MeSH
- radionuklidy chemie MeSH
- vazba proteinů MeSH
- vysokoúčinná kapalinová chromatografie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- srovnávací studie MeSH
BACKGROUND: Somatostatin analogues labelled with radiometals or radiohalogens are useful for the imaging and treatment of somatostatin receptor-containing tumours. In this study, the procedures for the radioiodination of glucose-Tyr3-octreotate (gluc-Tyr3-tate) and radiolabelling of DOTA-Tyr3-octreotate (DOTA-Tyr3-tate) with 111In, 177Lu and 125I were compared and their metabolism in rats was analyzed. The usefulness of high performance liquid chromatography (HPLC) analysis and instant thin-layer chromatography on silica gel (ITLC-SG) for both radiochemical purity determination and analysis of metabolism in urine was investigated. MATERIALS AND METHODs: For labelling with radiometals, the formation of a complex with the 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) functionality of the peptide was employed. Radioiodination was performed by the chloramime-T method. The radiochemical purity of radiolabelled peptides and the analyses of rat urine were determined by HPLC and/or ITLC-SG methods. Male Wistar rats were used in the elimination studies. RESULTS: DOTA-Tyr3-tate was simply radiolabelled with radiometals with high yield and high radiochemical purity. Stopping of the reaction was a critical step for radioiodination, therefore labelling of gluc-Tyr3-tate and DOTA-Tyr3-tate with 125I was not so simple and the reaction product had to be purified by preparative HPLC analysis. Whereas 111In-DOTA-Tyr3-tate and 177Lu-DOTA-Tyr3-tate were eliminated in rat urine in a practically unchanged form, a significant proportion of metabolites was observed with radioiodinated peptides, particularly at longer time intervals. CONCLUSION: Labelling of DOTA-Tyr3-tate with radiometals is simple and the radiochemical purity of prepared compounds is very high, while iodination of the peptides demands purification of the product by preparative HPLC. The analysis of rat urine showed that excretion of radioiodinated peptides included a significant proportion of metabolites.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10026704
- 003
- CZ-PrNML
- 005
- 20111210192433.0
- 008
- 101028s2007 gr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Petřík, Miloš $7 xx0169395
- 245 10
- $a Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate / $c M Petrik, A Laznickova, M Laznicek, MR Zalutsky
- 314 __
- $a Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.
- 520 9_
- $a BACKGROUND: Somatostatin analogues labelled with radiometals or radiohalogens are useful for the imaging and treatment of somatostatin receptor-containing tumours. In this study, the procedures for the radioiodination of glucose-Tyr3-octreotate (gluc-Tyr3-tate) and radiolabelling of DOTA-Tyr3-octreotate (DOTA-Tyr3-tate) with 111In, 177Lu and 125I were compared and their metabolism in rats was analyzed. The usefulness of high performance liquid chromatography (HPLC) analysis and instant thin-layer chromatography on silica gel (ITLC-SG) for both radiochemical purity determination and analysis of metabolism in urine was investigated. MATERIALS AND METHODs: For labelling with radiometals, the formation of a complex with the 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) functionality of the peptide was employed. Radioiodination was performed by the chloramime-T method. The radiochemical purity of radiolabelled peptides and the analyses of rat urine were determined by HPLC and/or ITLC-SG methods. Male Wistar rats were used in the elimination studies. RESULTS: DOTA-Tyr3-tate was simply radiolabelled with radiometals with high yield and high radiochemical purity. Stopping of the reaction was a critical step for radioiodination, therefore labelling of gluc-Tyr3-tate and DOTA-Tyr3-tate with 125I was not so simple and the reaction product had to be purified by preparative HPLC analysis. Whereas 111In-DOTA-Tyr3-tate and 177Lu-DOTA-Tyr3-tate were eliminated in rat urine in a practically unchanged form, a significant proportion of metabolites was observed with radioiodinated peptides, particularly at longer time intervals. CONCLUSION: Labelling of DOTA-Tyr3-tate with radiometals is simple and the radiochemical purity of prepared compounds is very high, while iodination of the peptides demands purification of the product by preparative HPLC. The analysis of rat urine showed that excretion of radioiodinated peptides included a significant proportion of metabolites.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krevní proteiny $x metabolismus $7 D001798
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $7 D002851
- 650 _2
- $a glukosa $x analogy a deriváty $x metabolismus $7 D005947
- 650 _2
- $a heterocyklické sloučeniny monocyklické $x chemie $x metabolismus $7 D006573
- 650 _2
- $a radioizotopy india $x chemie $7 D007205
- 650 _2
- $a radioizotopy jodu $x chemie $7 D007457
- 650 _2
- $a izotopové značení $7 D007553
- 650 _2
- $a lutecium $x chemie $7 D008187
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a cyklické peptidy $x chemie $x metabolismus $7 D010456
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a radionuklidy $x chemie $7 D011868
- 650 _2
- $a radiofarmaka $x chemická syntéza $x metabolismus $7 D019275
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a financování organizované $7 D005381
- 655 _2
- $a srovnávací studie $7 D003160
- 700 1_
- $a Lázníčková, Alice, $d 1948- $7 nlk19990073515
- 700 1_
- $a Lázníček, Milan, $d 1947- $7 nlk19990073514
- 700 1_
- $a Zalutsky, Michael R
- 773 0_
- $w MED00000478 $t Anticancer research $g Roč. 27, č. 6B (2007), s. 3941-3946 $x 0250-7005
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20101028150601 $b ABA008
- 991 __
- $a 20101029152815 $b ABA008
- 999 __
- $a ok $b bmc $g 801811 $s 666567
- BAS __
- $a 3
- BMC __
- $a 2007 $b 27 $c 6B $d 3941-3946 $i 0250-7005 $m Anticancer research $n Anticancer Res $x MED00000478
- LZP __
- $a 2010-B3/vtme